Absci (ABSI) Enterprise Value (2020 - 2026)
Absci (ABSI) reported Enterprise Value of -$125.7 million for Q1 2026, up 6.18% on a YoY basis from -$118.4 million in Q1 2025, and up 12.88% sequentially from -$144.3 million in Q4 2025.
Absci (ABSI) Enterprise Value (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Enterprise Value data on file, last reported at -$125.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 6.18% year-over-year to -$125.7 million; the trailing twelve-month figure through Mar 2026 stood at -$125.7 million (up 6.18% YoY), and the FY2025 full-year result was -$144.3 million, down 28.35% from the prior year.
- Enterprise Value grew to -$125.7 million in Q1 2026, from -$144.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$50.0 million in Q2 2022 to a low of -$226.0 million in Q1 2022.
- A 5-year average of -$136.6 million and a median of -$134.0 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 180.74% in 2022 and surged 40.61% in 2023, its largest moves.
- Tracing ABSI's Enterprise Value over 5 years: stood at -$164.4 million in 2022, then surged by 40.61% to -$97.7 million in 2023, then declined by 15.12% to -$112.4 million in 2024, then decreased by 28.35% to -$144.3 million in 2025, then climbed by 12.88% to -$125.7 million in 2026.
- Business Quant data shows ABSI's Enterprise Value at -$125.7 million in Q1 2026, -$144.3 million in Q4 2025, and -$152.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -125.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125.71 Mn |
| Dec 31, 2025 | -144.29 Mn |
| Sep 30, 2025 | -152.48 Mn |
| Jun 30, 2025 | -117.46 Mn |
| Mar 31, 2025 | -133.98 Mn |
| Dec 31, 2024 | -112.43 Mn |
| Sep 30, 2024 | -127.07 Mn |
| Jun 30, 2024 | -145.25 Mn |
| Mar 31, 2024 | -161.54 Mn |
| Dec 31, 2023 | -97.66 Mn |
| Sep 30, 2023 | -113.48 Mn |
| Jun 30, 2023 | -124.59 Mn |
| Mar 31, 2023 | -144.26 Mn |
| Dec 31, 2022 | -164.43 Mn |
| Sep 30, 2022 | -181.31 Mn |
| Jun 30, 2022 | -50.00 Mn |
| Mar 31, 2022 | -226.00 Mn |
| Dec 31, 2021 | -252.57 Mn |
| Sep 30, 2021 | -279.26 Mn |
| Jun 30, 2021 | 61.93 Mn |